Approval · Notice of Compliance 13977 · 2013
DAXAS: Notice of Compliance 13977
Issued January 2, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13977
- Date
- January 2, 2013
- Company
- Takeda Canada IncorporatedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Phosphdiesterase R (pde4) inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DAXAS | 02359456 | Marketed |
Medicinal ingredients
- ROFLUMILAST 500 MCG per TAB